Lexpos News

Community Pharmacy England is looking for a Head of Finance to join our Pharmacy Funding Team. This post offers the opportunity to fulfil a senior finance and central administration role as part of a small friendly supportive organisation. The Head of Finance will be responsible for implementing financial policies and procedures, preparing financial statements and reports, [...]

The post Head of Finance job opportunity appeared first on Community Pharmacy England.

Community pharmacy owners and their teams only have a few days left to share their experiences through the 2024 Pharmacy Pressures Survey before it closes at 23.59 on Tuesday 2nd April. We are encouraging everyone who works in a community pharmacy in England to tell us more about the ongoing impact of key issues such [...]

The post Final call to share pressures views appeared first on Community Pharmacy England.

Community pharmacy owners are reminded, that the incentive fee payable for reaching the year-5 specified ambulatory blood pressure monitoring (ABPM) threshold for the Hypertension Case-Finding Service ends on 31st March 2024. Pharmacy owners who have been working to meet the threshold of 20 ABPM checks for 2023/24 to be eligible for the incentive fee, must [...]

The post Hypertension Case-Finding Service: Important reminder on end of ABPM incentive appeared first on Community Pharmacy England.

Community pharmacy owners are reminded that the Lateral flow device tests supply service for patients potentially eligible for COVID-19 treatments (LFD service) will expand to additional patient groups from 1st April 2024. As previously announced, further details on the continued commissioning of the service and the additional patient groups are available on the LFD service page. [...]

The post Reminder: New eligible patient groups for LFD service start from 1st April appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 8 March 2024) has been published and includes articles on: Letters and medicine recalls sent to healthcare professionals in February 2024. To see the la...